Access cutting-edge advanced solid tumor treatment through this clinical trial at a research site in Saint Louis Park. Study-provided care at no cost to qualified participants.
Access advanced solid tumor specialists in Saint Louis Park at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumor treatment provided free
This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors. The study is enrolling cohorts of participants with melanoma \[cutaneous/acral\], squamous cell carcinomas of the head and neck (SCCHN), HER2-negative gastric cancer ovarian carcinoma, cervical cancer, endometrial cancer, bladder cancer, esophageal carcinoma, pancreatic carcinoma, prostate cancer, second-line gastric cancer, lung cancer, and breast cancer.
Sponsor: Daiichi Sankyo
Check if you qualify for this advanced solid tumor clinical trial in Saint Louis Park, MN
If you're searching for advanced solid tumor treatment options in Saint Louis Park, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Saint Louis Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.